Skip to content
DataLookout
Menu

COPERNICANNCT06353594

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 2026 to Mar 2028
    • Eligibility criteria expanded, about 11 words
    • Collaborators: 1 to 2
    • Publications: details revised at 1 of 1 entry
  2. Notable Lead sponsor: Jorge Sanz Sanchez to Hospital Universitario La Fe
    • Study sites: 15 to 23
    • Collaborators expanded, about 1 word
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Target lesion failure (TLF)
Timeframe: 12 months

Secondary (9)

Incidence of all-cause death
Incidence of myocardial infarction
Incidence of cardiovascular death
Incidence of target lesion revascularization
Incidence of stent thrombosis
Show 4 moreShow less
Incidence of acute vessel closure
Incidence of stroke
Incidence of acute kidney injury
Incidence of bleeding

Arms and interventions

DCB-basedExperimental

Reduced stent PCI strategy: Culprit lesion revascularization with DCB will be performed after coronary predilation if residual stenosis ≤30%, lack of dissections \>type B and TIMI 3 flow. If the aforementioned culprit-lesion characteristics are not achieved after DCB-PCI, a DES will be implanted.

DES-basedNo intervention

Control group

Devices: Primary PCI

Sites

23 sites in 1 country